The Fanconi anemia pathway induces chromothripsis and ecDNA-driven cancer drug resistance

By sjmartinez • August 27, 2024

Engel JL, Zhang X, Wu M, Wang Y, Espejo Valle-Inclán J, Hu Q, Woldehawariat KS, Sanders MA, Smogorzewska A, Chen J, Cortés-Ciriano I, Lo RS, Ly P. The Fanconi anemia pathway induces chromothripsis and ecDNA-driven cancer drug resistance. Cell. 2024 Aug 20:S0092-8674(24)00892-4. doi: 10.1016/j.cell.2024.08.001. Epub ahead of print. PMID: 39181133.

Tags: chromothripsis, Dermatology, DNA repair, DNA replication, ecDNA, Fanconi anemia, fragile sites, genome rearrangements, genomic instability, micronuclei, mitosis, Post Doc, Publications

Related Posts

A review of the indications, safety, and efficacy of deucravacitinib: An expert consensus panel

Shah M, DeBusk L, Bohman MH, Rosenberg A, Burshtein J, Zakria D, Armstrong A, Boh E, Gottlieb AB, Khattri S, Litchman G, Merola J, Murina[...]

The efficacy and safety of interleukin-17 and interleukin-23 inhibitors in psoriatic arthritis across multiple disease domains

Zakria D, Shah M, Rosenberg A, Burshtein J, DeBusk L, Altman DA, Armstrong AW, Gottlieb AB, Han G, Khattri S, Shaigany S, Weinberg JM, Lebwohl[...]

Vitiligo in the United States: A 10-year study of patient characteristics, comorbidities, and treatment patterns

Huang MY, Smart K, Lee K, Kingston P, Yee D, Peterson H, Korouri E, Armstrong AW. Vitiligo in the United States: A 10-year study of[...]